Tumor Cell Targeting by Iron Oxide Nanoparticles Is Dominated by Different Factors In Vitro versus In Vivo
暂无分享,去创建一个
Christian NDong | Karl E. Griswold | P. J. Hoopes | P. Jack Hoopes | Warren C. Kett | E. Demidenko | T. Gerngross | C. Ndong | K. Griswold | W. Kett | J. Tate | L. Lewis | Eugene Demidenko | Jennifer A. Tate | Tillman U. Gerngross | J. Batra | Jaya Batra | Lionel D. Lewis | P. Hoopes | Jennifer A. Tate | C. NDong
[1] I. Baker,et al. MAGNETIC NANOPARTICLE HYPERTHERMIA IN CANCER TREATMENT. , 2010, Nano LIFE.
[2] Taeghwan Hyeon,et al. Inorganic Nanoparticles for MRI Contrast Agents , 2009 .
[3] W. Kaiser,et al. Iron oxide-based nanostructures for MRI and magnetic hyperthermia. , 2012, Nanomedicine.
[4] G. Liu,et al. Targeted Herceptin–dextran iron oxide nanoparticles for noninvasive imaging of HER2/neu receptors using MRI , 2009, JBIC Journal of Biological Inorganic Chemistry.
[5] S. Barry,et al. Phagocytes mediate targeting of iron oxide nanoparticles to tumors for cancer therapy. , 2013, Integrative biology : quantitative biosciences from nano to macro.
[6] N. Gu,et al. Effective PEGylation of Iron Oxide Nanoparticles for High Performance In Vivo Cancer Imaging , 2011 .
[7] Serena Mazzucchelli,et al. HER2 expression in breast cancer cells is downregulated upon active targeting by antibody-engineered multifunctional nanoparticles in mice. , 2011, ACS nano.
[8] S. Kasaoka,et al. Tumor regression by inductive hyperthermia combined with hepatic embolization using dextran magnetite-incorporated microspheres in rats. , 2000, International journal of oncology.
[9] S. Akilesh,et al. FcRn: the neonatal Fc receptor comes of age , 2007, Nature Reviews Immunology.
[10] M. Jafelicci,et al. Iron Oxide Versus Fe $_{55}$ Pt $_{45}$ /Fe $_{3}$ O $_{4}$ : Improved Magnetic Properties of Core/Shell Nanoparticles for Biomedical Applications , 2008 .
[11] Lily Yang,et al. Anti-HER2 antibody and ScFvEGFR-conjugated antifouling magnetic iron oxide nanoparticles for targeting and magnetic resonance imaging of breast cancer , 2013, International journal of nanomedicine.
[12] R. Gilchrist,et al. Selective Inductive Heating of Lymph Nodes , 1957, Annals of surgery.
[13] Warren C W Chan,et al. Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. , 2007, Nano letters.
[14] Dar-Bin Shieh,et al. Iron oxide nanoparticles for targeted cancer imaging and diagnostics. , 2012, Nanomedicine : nanotechnology, biology, and medicine.
[15] W. Kaiser,et al. Developments for the minimally invasive treatment of tumours by targeted magnetic heating , 2006 .
[16] P. Moroz,et al. Magnetically mediated hyperthermia: current status and future directions , 2002, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[17] I. Chourpa,et al. Optimization of iron oxide nanoparticles encapsulation within poly(d,l-lactide-co-glycolide) sub-micron particles. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[18] N. K. Prasad,et al. Mechanism of cell death induced by magnetic hyperthermia with nanoparticles of γ-MnxFe2–xO3 synthesized by a single step process , 2007 .
[19] Sabino Veintemillas-Verdaguer,et al. The influence of surface functionalization on the enhanced internalization of magnetic nanoparticles in cancer cells , 2009, Nanotechnology.
[20] Earl J. Bergey,et al. DC Magnetic Field Induced Magnetocytolysis of Cancer Cells Targeted by LH-RH Magnetic Nanoparticles in vitro , 2002 .
[21] G. Nienhaus,et al. Engineered nanoparticles interacting with cells: size matters , 2014, Journal of Nanobiotechnology.
[22] R. Ivkov,et al. Development of Tumor Targeting Bioprobes (111In-Chimeric L6 Monoclonal Antibody Nanoparticles) for Alternating Magnetic Field Cancer Therapy , 2005, Clinical Cancer Research.
[23] R. Lu,et al. Single chain antic-Met antibody conjugated nanoparticles for in vivo tumor-targeted imaging and drug delivery , 2022 .
[24] Tsuneo Imai,et al. Anti-cancer effect of hyperthermia on breast cancer by magnetite nanoparticle-loaded anti-HER2 immunoliposomes , 2009, Breast Cancer Research and Treatment.
[25] Yu Zhang,et al. Therapeutic effect of Fe2O3 nanoparticles combined with magnetic fluid hyperthermia on cultured liver cancer cells and xenograft liver cancers. , 2005, Journal of nanoscience and nanotechnology.
[26] D. Leslie-Pelecky,et al. Biodistribution, clearance, and biocompatibility of iron oxide magnetic nanoparticles in rats. , 2008, Molecular pharmaceutics.
[27] Lily Yang,et al. Anti-HER2 antibody and ScFvEGFR-conjugated antifouling magnetic iron oxide nanoparticles for targeting and magnetic resonance imaging of breast cancer , 2013, International journal of nanomedicine.
[28] Abiche H. Dewilde,et al. Herceptin-directed nanoparticles activated by an alternating magnetic field selectively kill HER-2 positive human breast cells in vitro via hyperthermia , 2011, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[29] Hiroyuki Honda,et al. Magnetite nanoparticle-loaded anti-HER2 immunoliposomes for combination of antibody therapy with hyperthermia. , 2004, Cancer Letters.
[30] Jerry S. H. Lee,et al. Magnetic nanoparticles in MR imaging and drug delivery. , 2008, Advanced drug delivery reviews.
[31] J. Bacri,et al. Some biomedical applications of ferrofluids , 1999 .
[32] D. Wei,et al. Discarded free PEG-based assay for obtaining the modification extent of pegylated proteins. , 2007, Talanta.
[33] Forrest M Kievit,et al. Surface engineering of iron oxide nanoparticles for targeted cancer therapy. , 2011, Accounts of chemical research.
[34] H. Hofmann,et al. Superparamagnetic nanoparticles for biomedical applications: Possibilities and limitations of a new drug delivery system , 2005 .
[35] Shuming Nie,et al. Single chain epidermal growth factor receptor antibody conjugated nanoparticles for in vivo tumor targeting and imaging. , 2008, Small.
[36] Klaus Jung,et al. Magnetic fluid hyperthermia (MFH)reduces prostate cancer growth in the orthotopic Dunning R3327 rat model , 2005, The Prostate.
[37] Jinho Park,et al. Targeting Strategies for Multifunctional Nanoparticles in Cancer Imaging and Therapy , 2012, Theranostics.
[38] B. Gray,et al. Treatment of experimental rabbit liver tumours by selectively targeted hyperthermia , 2002, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[39] I. Chourpa,et al. Nanovectors for anticancer agents based on superparamagnetic iron oxide nanoparticles , 2007, International journal of nanomedicine.
[40] P. Wust,et al. Magnetic fluid hyperthermia (MFH): Cancer treatment with AC magnetic field induced excitation of biocompatible superparamagnetic nanoparticles , 1999 .
[41] Han-Chung Wu,et al. Single chain anti-c-Met antibody conjugated nanoparticles for in vivo tumor-targeted imaging and drug delivery. , 2011, Biomaterials.
[42] Warren C W Chan,et al. Mediating tumor targeting efficiency of nanoparticles through design. , 2009, Nano letters.
[43] Arutselvan Natarajan,et al. Thermal dosimetry predictive of efficacy of 111In-ChL6 nanoparticle AMF--induced thermoablative therapy for human breast cancer in mice. , 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[44] J. Zee. Heating the patient : a promising approach ? , 2002 .
[45] Serena Mazzucchelli,et al. Assessing the in vivo targeting efficiency of multifunctional nanoconstructs bearing antibody-derived ligands. , 2013, ACS nano.
[46] I. Lucet,et al. Development of superparamagnetic nanoparticles for MRI: effect of particle size, charge and surface nature on biodistribution. , 1996, Journal of microencapsulation.
[47] J. Ravetch,et al. Antibodies, Fc receptors and cancer. , 2007, Current opinion in immunology.
[48] C. N. Ramchand,et al. Application of magnetic fluids in medicine and biotechnology , 2001 .
[49] C. Hadjipanayis,et al. EGFRvIII antibody-conjugated iron oxide nanoparticles for magnetic resonance imaging-guided convection-enhanced delivery and targeted therapy of glioblastoma. , 2010, Cancer research.
[50] Forrest M Kievit,et al. Targeting of primary breast cancers and metastases in a transgenic mouse model using rationally designed multifunctional SPIONs. , 2012, ACS nano.
[51] A. Domb,et al. Exploiting EPR in polymer drug conjugate delivery for tumor targeting. , 2006, Current pharmaceutical design.
[52] Ingrid Hilger,et al. Thermal Ablation of Tumors Using Magnetic Nanoparticles: An In Vivo Feasibility Study , 2002, Investigative radiology.
[53] Sumit Arora,et al. Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers , 2012, International journal of nanomedicine.